Background {#Sec1}
==========

Extramedullary plasmacytoma (EMP) comprises approximately 3--5 % of all plasma cell neoplasms. Eighty percent of EMP occurs in the head and neck, and most cases involve the upper aerodigestive tract \[[@CR1]\]. Primary pulmonary plasmacytoma (PPP) is a rare type of extramedullary plasmacytoma. In a comprehensive literature search reviewing patients with EMPs in English language literature, only 11 reports were found \[[@CR2]--[@CR10]\] (summarized in Table [1](#Tab1){ref-type="table"}), and cases that were described include clinical therapy and prognosis. Here, we present an extremely unusual presentation as a pulmonary mass and without bone marrow involvement or other characteristics of multiple myeloma.Table 1Summary of the literature on the clinical treatment and prognosis of primary pulmonary plasmacytomaAuthor, yearAgeGenderExtensionTreatmentPrognosisNozomi Niitsu, 2005 \[[@CR9]\]71WomanA tumor in the right middle lobeChemotherapyAfter completing three courses of the therapy, considerable diminution in the sizeMontero C, 2009 \[[@CR6]\]59ManA tumor in the left main bronchus and enlarged subcarinal lymph nodesSurgical and radiotherapyCurrently asymptomatic and has remained disease free during a follow-up of 10 yearsMontero C, 2009 \[[@CR6]\]64ManA mass in the right upper lobeRadiotherapyA disease-free period of 15 years followedMontero C, 2009 \[[@CR6]\]56ManA mass and reduced right upper lobe volumeRadiotherapeutic and adjuvant chemotherapyDeveloped fever and signs of septic shock during the third cycle and diedGeetha Joseph, M.D. \[[@CR2]\]79ManA right hilar massRight middle lobectomyNot mentionedSang-Heon Kim, 2012 \[[@CR5]\]26WomanInfiltrative lesions in both lower lung fieldsChemotherapyNear complete radiological resolution was observed after six cycles of treatmentZ. Mohammad Taheri, 2010 \[[@CR4]\]60WomanBilateral alveolar consolidationChemotherapyAfter four monthly courses, the chest X-ray became normalShi-Ping Luh, 2007 \[[@CR7]\]42WomanRight anterior mediastinal shadow with multiple pulmonary nodular lesions.Surgical and chemotherapySymptoms improved after 2 months of treatmentTakahiro Horiuchi, MD, 1998 \[[@CR10]\]45WomanMassive parenchymal infiltrate in the lower lobesChemotherapyAfter four monthly courses, the chest X-ray became normalLenara Renó Arbex Coelho, 2015 \[[@CR8]\]53ManOvoid opacity in the right hilar regionRadiotherapyAfter 3 years, no suspect finding of disease recurrence/progressionJames N. Wise, 2001 \[[@CR3]\]65ManA right hilar massA right thoracotomy with right upper lobectomyFifteen months postoperatively, without evidence of recurrence

Case presentation {#Sec2}
=================

A 48-year-old male with a tumor in the right middle ear was referred to our hospital. A routine chest X-ray was arranged and showed enlargement of the left lung hilum. His vital signs were as follows: blood pressure 117/75 mmHg, pulse 93/min, breathing 20/min, body temperature 36.3 °C. There was no systemic or superficial lymph node enlargement, sinus area tenderness, or swollen tonsils. The trachea was in the mid-line. The patient had a barrel chest. His bilateral breathing sounds are clear. Bronchoscopy revealed no obvious abnormal findings. The patient underwent a series of evaluations such as serum calcium, urine Bence-Jones protein, and plasma electrophoresis for M protein detection. However, all of the above tests were negative. A bone marrow biopsy revealed normal patterns of cell distribution. He had an approximately 10-year history of smoking. He had a tumor in the right tympanic cavity surgically removed with a postoperative pathological diagnosis of extramedullary plasmacytoma. He had no history of tuberculosis (TB). No family members had any similar clinical manifestations nor had any died of similar diseases.

A chest computed tomography (CT) scan demonstrated a well-circumscribed mass measuring 2.7 × 1.5 × 2.5 cm located in left lower lobe dorsal segment (Fig. [1a, b](#Fig1){ref-type="fig"}). The mass was homogeneous and without any area of calcification or necrosis on a CT plain scan. It was marginal, lobulated, and spiculated with adjacent pleural retraction and caused bronchiolar obstruction. Enhanced scanning revealed that the nodule displayed moderate uniform reinforcement, and tiny blood vessels could be observed (Fig. [1c](#Fig1){ref-type="fig"}). No obvious enlarged lymph nodes were found in the mediastinum. CT data resulted in a diagnosis of peripheral lung cancer. A skull, spine, and pelvis X-ray revealed no osteolytic lesions.Fig. 1**a**\~**d** Pulmonary plasmacytoma. **a** Chest CT lung window shows a well-circumscribed mass in the inferior lobe of the left lung, fine burrs in marginal lobulated, adjacent pleural retraction. **b** Chest CT mediastinal window on a plain scan shows that the nodule was homogeneous. **c** CT enhancement scanning shows that the nodule displayed moderate uniform reinforcement; **d** Microscope shows more amount of plasma cell distribution, large cells, nuclear round or ovoid, same size, often offset, chromatin spokes shaped, generally no nucleoli, nuclear fission as rare, abundant cytoplasm, many basophils (HE × 100)

A CT-guided needle aspiration biopsy specimen showed that, microscopically, plasma cells were situated in the fibrous tissue, and the cells were larger than normal with Russell bodies. Small blood vessels were also revealed (Fig. [1d](#Fig1){ref-type="fig"}); immunohistochemical kappa (+++) predominate, lambda (−), CD20 (−), CD79a (−), CD138 (+++), CD38 (+++). Pathological biopsy indicated isolated pulmonary plasmacytoma.

The patient was treated with chemotherapy alone. After 6 months, the chest X-ray became normal and the patient was free of symptoms. The patient remained disease free during a follow-up of 1.5 years. Now, he is still in follow-up.

Discussion {#Sec3}
----------

Plasma cell neoplasms can be classified into the following types: multiple myeloma (bone marrow and other systemic involvements), solitary myeloma (bone plasmacytoma), extramedullary (soft tissue) plasmacytoma, and plasmablastic sarcoma \[[@CR11]\].

### Clinical manifestations {#Sec4}

EMP affects males three to four times more often than females, with an average age of 55. However, one third of patients with EMP are under 50 years old. The etiology of the disease is not well understood, but viral pathogenesis and chronic irritation are suggested to be contributing factors \[[@CR12]\]. It presents with non-specific symptoms, such as chronic cough, dyspnea, wheezing, huskiness, or hemoptysis. The presentation is closely related with lesion location. Violation of the trachea can result in a series of symptoms such as breathlessness and difficulty of breathing; bronchial tumor invasion may appear as blood in phlegm or hemoptysis. If there is any involvement of the pleura, the patient may experience symptoms such as chest pain and systemic symptoms are not obvious. In this case, the patient may not exhibit symptoms for a long time, have no obvious symptoms of cough, or coughing up phlegm or symptoms such as chest pain. The clinical staging of PPP was generally based on the Wilshaw method, divided into three stages as follows: stage I: the tumor is confined to the primary site; stage II: the tumor has invaded local lymph nodes; stage III: there are obvious widespread metastases. Therefore, in this case, the clinical staging should be classified as stage I.

### Laboratory examination {#Sec5}

Solitary extramedullary plasmacytoma of the lung is extremely rare; pulmonary involvement with multiple myeloma is more common.

To differentiate solitary EMP from multiple myeloma, bone marrow examination is required. The patient should have lower than 5 % plasma cells with no dyscrasia and a normal skeletal survey. Unlike multiple myeloma, EMPs may not have serum M protein or Bence-Jones light chains in the urine. After treatment, the review should detect the M protein level, and testing a bone marrow is essential for ruling out multiple myeloma.

### Histopathological characteristics {#Sec6}

PPP microscopically showed dense plasma cells and different levels of diffuse proliferation and infiltration. Mature and relative mature nuclei are round or ovoid, of the same size, often offset, with spoke-shaped chromatin and generally no nucleoli. Nuclear fission is rare and cytoplasm is abundant. These cells are primarily basophilic and the minority as eosinophilic. The nucleus is peripheral or one side is surrounded by perinuclear halos. Irregular immature plasma cells have a low nuclear membrane thickness, scattered chromatin n spoke-shaped arrangement, and clear dual-core nucleolus. Nuclear fission is common. Cells have less cytoplasm and are basophilic or eosinophilic. Immunohistochemical staining reveals single light chain expression, namely kappa lambda (−) or (+) or kappa lambda (+/−) predominate. Tumor cells were CD20 (−), CD79a (++), CD138 (++), and CD38 part (+) \[[@CR4]\]. These features are in accordance with the typical histopathological characteristics of PPP. The immune phenotype is highly specific for the diagnosis of plasmacytoma, especially the expression of CD138.

### Image diagnosis and differential {#Sec7}

The CT findings of PPP are more likely to be solitary pulmonary nodules or shadow masses, localized to the lung hilar region, with a tendency to be in the lower lobus, forming a round or round-like shape 1.5\~6.0 cm in diameter, with relatively uniform density \[[@CR13]\] occasionally empty and clear edges. PPP displaying multiple shadowed masses is rare but has been reported \[[@CR14]\]. Some patients with diffuse bilateral lung distribution can be revealed by lung consolidation through a CT scan, which implies that tumor cells infiltrate into the lung parenchyma \[[@CR2], [@CR7], [@CR9], [@CR10]\]. In this case report, the patient's CT revealed an isolated lung nodule and no lymph node involvement. PPP usually presents as single or multiple nodules in the lung so is often misdiagnosed as focal organizing pneumonia, tuberculosis, or lung cancer (summarized in Table [2](#Tab2){ref-type="table"}).Table 2CT diagnosis and differential diagnosis of PPPPPPPeripheral lung cancerTuberculomaNodular focal organizing pneumoniaLobuleSuperficial lobeDeep lobulesNo lobuleNo lobuleRimFine burr shadowShort hard burrsLong burrs, satellite lesionsPeripheral visible burrsDensityRelatively uniform density, occasionally emptyMost uneven, jagged hole in the inner wallCalcification, hollow with smooth inner wallUneven density, pus cavityEnhanced CT scanModerate uniform reinforcementObvious strengtheningNo or light enhancementUniform or delayed enhancementPleuralPleural retractionSubpleural focal fatty infiltrationPleural thickening/calcificationAdjacent pleural thickening

In this case, the presentation was isolated lung nodules, lobulated, rim visible, fine burr shadow, and pleural retraction and was initially misdiagnosed as peripheral lung cancer. However, that condition is often characterized by deep lobules, short hard burrs, accompanied by jagged cavity, and lesions containing stiff gas bronchial wall that may be truncated, and involvement of the pleura can blur the subpleural fat gap. An enhanced CT scan showed obvious strengthening at approximately 20\~60 HU.

In this case, the lesion location in left lower lobe dorsal segment was characterized by isolated soft tissue nodular shadows, differentiating it from tuberculosis. Tuberculoma often presents with calcification, more satellite lesions around the nodule, hollow with smooth inner wall, and the enhanced scan is no or light improved. There are clinical case reports of PPP lesions with calcifications \[[@CR15]\], so calcification does not exclude the possibility of PPP. Therefore, a clinical laboratory examination is necessary for the diagnosis of tuberculosis.

In this case, it showed an isolated lung lesion with a less clear boundary, which also differentiates it from nodular focal organizing pneumonia. The edge of focal organizing pneumonia can be clear or fuzzy, its lesions have uneven density, liquefied necrotic tissue forms hollows, and it presents with peripheral visible burrs. Enhanced scanning can show lesions uniform or peripheral enhancement with adjacent pleural thickening and pus cavity.

### Treatment and prognosis {#Sec8}

Primary pulmonary plasmacytoma consisting of a solitary lesion is usually treated by either surgical resection alone or resection followed by radiation therapy. But the previous three cases of diffuse pulmonary infiltration and one case of multiple lung nodules, as well one case of a tumor in each lung underwent combination chemotherapy including melphalan and prednisolone \[[@CR5], [@CR9], [@CR10]\]. In this case, because of the small size of the lesion, we recommended chemotherapy to patients who previously had a history of surgery and in poor health.

Conclusions {#Sec9}
===========

We presented a case of PPP with an isolated lung nodule and no lymph node involvement. An isolated lung nodule showed superficial lobe, fine burr shadow, pleural retraction, and moderate uniform reinforcement; we should take into account the possibility of PPP. When the mass is small, not appropriate for operation, we can put chemotherapy as the preferred solution.
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